[IGF-I, VEGF and bFGF as predictive factors for the onset of retinopathy of prematurity (ROP)].
OBJECTIVE
To determine if IGF-I, VEGF and bFGF, present in the serum of premature infants, are independent risk factors of the development of ROP. It was also our objective to design a multivariate model that included these three cytokines as indicator parameters in the ROP screening, in addition to the other parameters already in existence.


METHODS
74 patients were recruited with a birth weight below 1500g or gestational age below 32 weeks. These were classified into those who developed ROP (N = 37) and those without ROP (N = 37). We obtained serum from each infant at the time of the first examination at 4-6 postnatal weeks. These samples were frozen until the time of analysis. The roles of gestational age and birth weight were also evaluated.


RESULTS
There were significant differences in the amount of the cytokines IGF-I and VEGF between the groups with or without ROP, but there were no significant differences for bFGF. The differences enabled us to establish a multivariate model including IGF-I and VEGF for the prediction of risk of ROP.


CONCLUSIONS
Cytokine serum levels in premature infants can be useful as an indicator in ROP screening, as well as being used to predict the probability of suffering the illness.
Villegas-Becerril
E
E
Servicio de Oftalmología, Hospital Reina Sofía de Córdoba, C/. Menéndez Pidal s/n, Córdoba, Spain. drvill@terra.es
González-Fernández
R
R
Perula-Torres
L
L
Gallardo-Galera
J M
JM
D016222:Fibroblast Growth Factor 2 / Q000097:blood*; D006801:Humans; D007231:Infant, Newborn; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D015999:Multivariate Analysis; D011237:Predictive Value of Tests; D012178:Retinopathy of Prematurity / Q000097:blood*; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*
D042461:Vascular Endothelial Growth Factor A; D016222:Fibroblast Growth Factor 2; D007334:Insulin-Like Growth Factor I